| Ytd | 61.94% | |
| 1y | 201.56% |
| Open | 40.50 | Prev Close | 40.50 | Low | 40.50 | High | 40.50 | Mkt Cap | 6.27B |
| Vol | 0.00 | Avg Vol | 2.94M | EPS | -1.79 | P/E | -22.63 | Forward P/E | -22.75 |
| Beta | 1.12 | Short Ratio | 1.35 | Inst. Own | 96.93% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 39.71 | 200-d Avg | 29.33 | 1yr Est | 40.25 |
CNTA News
Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - Global UAV Technologies Ltd. (CSE: U
BOSTON and LONDON, June 22, 2026 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a
Proven Chief Medical Officer at several publicly listed and clinical-stage oncology companies with s
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
B. Metzler seel. Sohn and Co. AG purchased a new position in Centessa Pharmaceuticals PLC Sponsored
Pre-Market Stock Futures: Futures are trading lower this morning after negotiations with Iran failed
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Centessa (NASDAQ: CNTA) for
Major M&A deals this week include: Eli Lilly's $7.8 billion purchase of Centessa Pharmaceuti
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA - Get Free Report)'s stock price hit a new
NEW YORK, April 1, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & As
Lilly is set to acquire Centessa for up to $7.8B, adds sleep disorder drugs and advances its push to
Pre-Market Stock Futures: Futures are trading higher after an explosive rally on Tuesday, sparked by
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
Centessa possesses a promising sleep medicine pipeline. The clinical-stage company's experimental th
Lilly to gain ownership of Centessa's OX2R agonist pipeline designed to improve outcomes across slee
Centessa Pharmaceuticals PLC (NASDAQ:CNTA) shares are surging today, last seen 44.4% higher to trade
U.S. stocks bounce sharply on Tuesday as lower Treasury yields and Trump's signals of a potentia
Eli Lilly has agreed to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion, mar
US stocks rise on Tuesday, with NASDAQ up 2% and Dow up 1.37%. Communication services shares gain 2.
Top Wall Street analysts changed outlook on top names. Needham downgrades CNTA, Baird downgrades PHR
MILWAUKEE, March 31, 2026 /PRNewswire/ -- LLP is investigating Centessa (NASDAQ: CNTA) for possible
Stocks are higher but all three major indexes are on track for monthly and quarterly losses
Eli Lilly to acquire Centessa Pharmaceuticals for $6.3B. CNTA stock surges 45% as Lilly expands its
US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen
During the Thursday's session, 100 stocks hit new 52-week lows.
On Monday, 149 companies reached new 52-week lows.
On Monday, 198 companies reached new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
On Monday, 524 stocks hit new 52-week lows.